Sequencing of agents for metastatic renal cell carcinoma: Can we customize ... - UroToday PDF Print
UroToday
The expanding armamentarium of agents for the therapy of advanced clear cell renal cell carcinoma (RCC) warrants further investigation of optimal patient selection. To analyze the second and subsequent line of targeted therapies for advanced RCC while

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.